Vermilion Life Sciences Ltd
Stuart is Chair of the Advisory Committee on Clinical Excellence Awards (ACCEA). He is a fully GMC registered physician, who trained in General Medicine and General Practice before gaining many years’ experience in senior leadership roles at Roche, GlaxoSmithKline, Norgine, Takeda and UCB. He is the Founder of Vermilion Life Sciences, which provides consultancy services to reduce the time and cost of medicines development to improve patient access.
Stuart is also an Authority Member of the Human Tissue Authority, a Board Trustee of the Faculty of Pharmaceutical Medicine, and has worked as an external ‘Champion'' for the UK Government''s Office for Life Sciences, Accelerated Access Review.
Reengineering Medicines Development
Exploring opportunities to reduce the cost and time of medicines development. How patient input, digital tools and real world data in real time can facilitate adaptive licensing and early regulator and payer discussions to generate early access.
EVEN MORE SEMINARS
Dr Penny Kechagioglou GenesisCare UK
Breast cancer Service of the Future: a service transformation
Professor Noel Clarke The Christie and Salford Royal Hospitals, Manchester UK
Improving Prostate Cancer Outcomes Through Cancer Trials
Prantik Das University Hospital of Derby and Burton NHS Foundation Trust
The Changing Landscape of Prostate Radiotherapy
Professor Jayant Vaidya University College London
Targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer
Geeta Shetty, MBBS, MS(Gen.Surg), DNB(Gen.Surg), DM, FRCS(Gen.Surg) Sandwell and West Birmingham Hospitals NHS Trust
Chest Wall Perforator Flaps for Partial Breast Reconstruction